NCT04454658 2025-07-16Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With MyelofibrosisAbbViePhase 1 Active not recruiting21 enrolled